Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Aspira Women's Health Inc.: Increased authorized common shares from 150,000,000 to 200,000,000, and total authorized shares to 205,000,000 (effective 2023-02-06).
- Change
- charter amendment
- Effective
- 2023-02-06
Exact text from the filing
On February 6, 2023, Aspira Women’s Health Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the authorized number of shares of the Company’s common stock from 150,000,000 shares to 200,000,000 shares, and accordingly to increase the total number of shares that the Company is authorized to issue to 205,000,000.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Aspira Women's Health Inc. shareholders approved Increase in authorized shares of common stock from 150,000,000 to 200,000,000 at the 2023-02-06 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-02-06
Exact text from the filing
Proposal 1: Increase in Authorized Shares The Company’s stockholders approved an amendment to the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock from 150,000,000 shares to 200,000,000 shares, and accordingly to increase the total number of shares that the Company is authorized to issue to 205,000,000. The final voting results were as follows: FOR AGAINST ABSTENTIONS BROKER NON-VOTES 93,255,545 1,238,679 167,583 0
View on SEC.gov